secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001641172-25-012192
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology increases authorized shares from 70M to 150M after stockholder approval
--------------------------------------------------------------------------------

- Stockholders approved amendment to certificate of incorporation on May 22, 2025.
- Certificate of Amendment filed with Delaware Secretary of State on same date.
- Authorized common stock raised from 70,000,000 to 150,000,000 shares.
- CEO Vlad Vitoc signed the filing on May 23, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225012192/0001641172-25-012192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225012192/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-012192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer